BioSpace News Archive

Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation cancer immunotherapies, today announced that its co-founder and chief executive officer, Dr. Darren Ji, will participate in a panel discussion about R&D and innovation leading cross-pacific collaboration.

Altesa BioSciences, Inc., an independently operated, for-profit biotechnology company today launched operations to develop and commercialize novel anti-viral drugs against common respiratory viruses like rhinovirus and parainfluenza, and vector-born global viral threats like Dengue fever, Yellow Fever, Zika, and Powassan.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, announced the withdrawal of the previously announced, proposed public offering.

CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer.

Alnylam Pharmaceuticals today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2021 and reviewed recent business highlights.

Biopharmaceutical R&D continued at a record-breaking pace in 2021 despite the COVID-19 pandemic, according to a new report, “Global Trends in R&D – Overview Through 2021,” by the IQVIA Institute for Human Data Science.

The Duke Quantum Center at Duke University and IonQ announced the invention of a new quantum computing operation with the potential to accelerate several key quantum computing techniques and contribute to scaling quantum algorithms.

LinKinVax, a clinical-stage biotechnology company is announcing completion of a €4.350 million seed capital funding round.

Biocept has appointed Darrell Taylor as Senior Vice President, General Counsel and Chief Compliance Officer.

Vaxcyte, Inc. today announced that Company management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 2:20 p.m. ET / 11:20 a.m. PT.